| Host: |
HEK293 cells |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Formulation: |
Lyophilised from a 0.22 Mu m filtered solution of PBS, pH 7.4. or Supplied as a 0.22 Mu m filtered solution in PBS, pH 7.4. |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Determination Method: |
< 1.0 EU/Mu g of the protein by LAL method. |
| Immunoreactivity: |
1.Measured by its binding ability in a functional ELISA. Immobilized Recombinant SARS-CoV-2 Spike S1 at 2 Mu g/mL (100 Mu L/well) can bind recombinant Human ACE2 with a linear range of 0.15-6.85 ng/mL.|2.Immobilized Human ACE2 on COOH Chip can bind S |
| Immunogen Region: |
Gln14-Arg683 |
| Immunogen: |
Recombinant SARS-CoV-2 (2019-nCoV) Spike S1 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Gln14-Arg683) of SARS-COV-2 (2019-nCoV) Spike S1 (Accession #YP_009724390.1) fused with a 6×His tag and |
| Immunogen Sequence: |
QCVNLTTRTQLPPAYTNSFT RGVYYPDKVFRSSVLHSTQD LFLPFFSNVTWFHAIHVSGT NGTKRFDNPVLPFNDGVYFA STEKSNIIRGWIFGTTLDSK TQSLLIVNNATNVVIKVCEF QFCNDPFLGVYYHKNNKSWM ESEFRVYSSANNCTFEYVSQ PFLMDLEGKQGNFKNLREFV FKNIDGYFKIYSKHTPINLV RDLPQGFSALEPLVDLPIGI NITRFQTLLALHRSYLTPG |
| Background | Recombinant SARS-CoV-2 (2019-nCoV) Spike S1 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Gln14-Arg683) of SARS-COV-2 (2019-nCoV) Spike S1 (Accession #YP_009724390.1) fused with a 6×His tag and Avi at the C-terminus. |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
